Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Value-Based Drug Reviews? US FDA Guidance Emphasizes “Accountability, Communication & Consistency”

Executive Summary

Updated Good Review Management Principles focus exclusively on “fundamental values and operational principles” underpinning the new drug review process – leaving nuts-and-bolts procedures to be spelled out elsewhere.

You may also be interested in...



One Lesson Of The OND Reorg: It Is Hard To Classify Diseases

One goal of proposed overhaul of US FDA’s Office of New Drugs is creating more logical alignment of related diseases within divisions and offices. That is easier said than done.

'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says

US guidances will be shorter and use a series of bullet points to communicate key ideas, replacing the current longer and wordier format.

Rx Import Legislation: One Step Forward, Two Steps Back – And Odd Dance Partners

The strange politics of prescription drug importation legislation in the US are on display again, this time in the context of the FDA user fee reauthorization bill. Including the topic in the bill is a ‘big deal’ – but probably makes imports less likely.

Topics

Latest News
UsernamePublicRestriction

Register

PS123985

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel